Progression on ibrutinib in patients with somatic mutations in the BCR and NF-kB pathways. Sun, C., Herman, S., Wu, C. J, Ahn, I., Rosebrock, D., Landau, D., Getz, G., Livitz, D., Leshchiner, I., Neuberg, D., & others In LEUKEMIA & LYMPHOMA, volume 58, pages 31–33, 2017. TAYLOR & FRANCIS LTD 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON ….
bibtex   
@inproceedings{sun2017progression,
  title={Progression on ibrutinib in patients with somatic mutations in the BCR and NF-kB pathways},
  author={Sun, Clare and Herman, Sarah and Wu, Catherine J and Ahn, Inhye and Rosebrock, Daniel and Landau, Dan and Getz, Gad and Livitz, Dimitri and Leshchiner, Ignaty and Neuberg, Donna and others},
  booktitle={LEUKEMIA \& LYMPHOMA},
  volume={58},
  pages={31--33},
  year={2017},
  organization={TAYLOR \& FRANCIS LTD 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON~…}
}

Downloads: 0